Home › RTI-HS, FDA partner to study patients' preferences that contributed to approval of new obesity device
 

Keywords :   


RTI-HS, FDA partner to study patients' preferences that contributed to approval of new obesity device

2015-02-02 14:32:07| Industrial Machines - Topix.net

RTI Health Solutions , a business unit of RTI International, partnered with the U.S. Food and Drug Administration to conduct a study on patients' preferences which contributed to the Agency's regulatory decision to approve the Maestro Rechargeable System, a first-of-kind device to treat obesity. In addition to clinical study results, FDA considered the study results to quantify patients' preferences for benefits and acceptability of risks of various obesity devices.

Tags: study partner device approval

Category:Industrial Goods and Services

Latest from this category

All news
18.06A Request From the A League of Their Own Womens Special Interest Group
18.06Next MANAchat Series is Scheduled for the Week of August 5
17.06New Federal Government Filing Requirement Regarding Ownership of LLCs and Corporations
17.06Manufacturers Reps That Sell to International Customers June 26 Networking Event
17.06Avoid $591 Daily Penalty From the U.S. Treasury Department
15.06With Gratitude for a Job Well Done
Industrial Goods and Services »
26.06Atlantic Tropical Weather Outlook
26.06Eastern North Pacific Tropical Weather Outlook
26.06XREAL bring Play Store apps to 3D space on XREAL AR glasses
26.06Qwilt reveals live streaming survey results
26.06Rockline Industries Wins WOW Innovation Award
26.06IMS Technologies Expands Calcinate Production Site
26.06Horizon expert 'gave evidence based on informal chats'
26.06Automotive Color by BASF Recognized with Renowned Red Dot Award
More »